Lexeo Therapeutics Stock (NASDAQ: LXEO) stock price, news, charts, stock research, profile.
You can purchase shares of Lexeo Therapeutics (NASDAQ:LXEO) through any online brokerage.
Other companies in Lexeo Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL) and Inozyme Pharma (NASDAQ:INZY).
Lexeo Therapeutics has a consensus price target of $22.71.
The stock price for Lexeo Therapeutics (NASDAQ: LXEO) is $6.28 last updated December 20, 2024 at 4:00 PM EST.
There are no upcoming dividends for Lexeo Therapeutics.
Lexeo Therapeutics’s Q4 earnings are confirmed for Friday, January 3, 2025.
There is no upcoming split for Lexeo Therapeutics.
Lexeo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.